{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T08:14:40Z","timestamp":1783757680930,"version":"3.55.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T00:00:00Z","timestamp":1778284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T00:00:00Z","timestamp":1778284800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cytotechnology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s10616-026-00978-w","type":"journal-article","created":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T05:09:47Z","timestamp":1778303387000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["miR-338-5p exerts neuroprotective effects in Parkinson\u2019s disease via targeting LRP1"],"prefix":"10.1007","volume":"78","author":[{"given":"Ni","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronghui","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heyue","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,9]]},"reference":[{"key":"978_CR1","doi-asserted-by":"publisher","first-page":"177830","DOI":"10.1016\/j.ejphar.2025.177830","volume":"1002","author":"SM Alshahrani","year":"2025","unstructured":"Alshahrani SM, Al-Kuraishy HM, Al-Gareeb AI, Albuhadily AK, Shokr MM, Kadasah SF, Alexiou A, Papadakis M, El-Saber Batiha G (2025) LRP1 at the crossroads of Parkinson\u2019s and Alzheimer\u2019s: Divergent roles in alpha-synuclein and amyloid pathology. Eur J Pharmacol 1002:177830","journal-title":"Eur J Pharmacol"},{"key":"978_CR2","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1055\/a-1460-8795","volume":"193","author":"S Aludin","year":"2021","unstructured":"Aludin S, Schmill LA (2021) MRI Signs of Parkinson\u2019s Disease and Atypical Parkinsonism. Rofo 193:1403\u20131410","journal-title":"Rofo"},{"key":"978_CR3","doi-asserted-by":"publisher","first-page":"104515","DOI":"10.1016\/j.phrs.2019.104515","volume":"150","author":"E Angelopoulou","year":"2019","unstructured":"Angelopoulou E, Paudel YN, Piperi C (2019) miR-124 and Parkinson\u2019s disease: A biomarker with therapeutic potential. Pharmacol Res 150:104515","journal-title":"Pharmacol Res"},{"key":"978_CR4","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1001\/jama.2019.22360","volume":"323","author":"MJ Armstrong","year":"2020","unstructured":"Armstrong MJ, Okun MS (2020) Diagnosis and Treatment of Parkinson Disease: A Review. JAMA 323:548\u2013560","journal-title":"JAMA"},{"key":"978_CR5","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.3233\/JPD-239005","volume":"13","author":"R Bhidayasiri","year":"2023","unstructured":"Bhidayasiri R, Kalia LV, Bloem BR (2023) Tackling Parkinson\u2019s Disease as a Global Challenge. J Parkinsons Dis 13:1277\u20131280","journal-title":"J Parkinsons Dis"},{"key":"978_CR6","first-page":"115","volume":"20","author":"S Bostantjopoulou","year":"2016","unstructured":"Bostantjopoulou S, Katsarou Z, Danglis I, Karakasis H, Milioni D, Falup-Pecurariu C (2016) Self-reported autonomic symptoms in Parkinson\u2019s disease: properties of the SCOPA-AUT scale. Hippokratia 20:115\u2013120","journal-title":"Hippokratia"},{"key":"978_CR7","doi-asserted-by":"publisher","first-page":"132","DOI":"10.31083\/j.jin2205132","volume":"22","author":"C Cattaneo","year":"2023","unstructured":"Cattaneo C, Jost WH (2023) Pain in Parkinson\u2019s Disease: Pathophysiology, Classification and Treatment. J Integr Neurosci 22:132","journal-title":"J Integr Neurosci"},{"key":"978_CR8","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13024-022-00560-w","volume":"17","author":"K Chen","year":"2022","unstructured":"Chen K, Martens YA, Meneses A, Ryu DH, Lu W, Raulin AC, Li F, Zhao J, Chen Y, Jin Y et al (2022) LRP1 is a neuronal receptor for alpha-synuclein uptake and spread. Mol Neurodegener 17:57","journal-title":"Mol Neurodegener"},{"key":"978_CR9","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/ane.13140","volume":"140","author":"XQ Chen","year":"2019","unstructured":"Chen XQ, Niu JP, Peng RQ, Song YH, Xu N, Zhang YW (2019) The early diagnosis of Parkinson\u2019s disease through combined biomarkers. Acta Neurol Scand 140:268\u2013273","journal-title":"Acta Neurol Scand"},{"key":"978_CR10","doi-asserted-by":"publisher","first-page":"102230","DOI":"10.1016\/j.arr.2024.102230","volume":"95","author":"L Du","year":"2024","unstructured":"Du L, Roy S, Wang P, Li Z, Qiu X, Zhang Y, Yuan J, Guo B (2024) Unveiling the future: Advancements in MRI imaging for neurodegenerative disorders. Ageing Res Rev 95:102230","journal-title":"Ageing Res Rev"},{"key":"978_CR11","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/bs.irn.2018.08.005","volume":"141","author":"M Filippi","year":"2018","unstructured":"Filippi M, Elisabetta S, Piramide N, Agosta F (2018) Functional MRI in Idiopathic Parkinson\u2019s Disease. Int Rev Neurobiol 141:439\u2013467","journal-title":"Int Rev Neurobiol"},{"key":"978_CR12","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s00702-022-02505-5","volume":"129","author":"PB Foley","year":"2022","unstructured":"Foley PB, Hare DJ, Double KL (2022) A brief history of brain iron accumulation in Parkinson disease and related disorders. J Neural Transm (Vienna) 129:505\u2013520","journal-title":"J Neural Transm (Vienna)"},{"key":"978_CR13","doi-asserted-by":"crossref","unstructured":"Goh SY, Chao YX, Dheen ST, Tan EK, Tay SS (2019) Role of MicroRNAs in Parkinson\u2019s Disease. Int J Mol Sci 20(22):5649.","DOI":"10.3390\/ijms20225649"},{"key":"978_CR14","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1007\/s00702-017-1717-8","volume":"124","author":"B Heim","year":"2017","unstructured":"Heim B, Krismer F, De Marzi R, Seppi K (2017) Magnetic resonance imaging for the diagnosis of Parkinson\u2019s disease. J Neural Transm (Vienna) 124:915\u2013964","journal-title":"J Neural Transm (Vienna)"},{"key":"978_CR15","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1212\/CON.0000000000000345","volume":"22","author":"CW Hess","year":"2016","unstructured":"Hess CW, Okun MS (2016) Diagnosing Parkinson Disease. Continuum (Minneap Minn) 22:1047\u20131063","journal-title":"Continuum (Minneap Minn)"},{"key":"978_CR16","doi-asserted-by":"publisher","first-page":"e0282684","DOI":"10.1371\/journal.pone.0282684","volume":"18","author":"KS Hwang","year":"2023","unstructured":"Hwang KS, Langley J, Tripathi R, Hu XP, Huddleston DE (2023) In vivo detection of substantia nigra and locus coeruleus volume loss in Parkinson\u2019s disease using neuromelanin-sensitive MRI: Replication in two cohorts. PLoS ONE 18:e0282684","journal-title":"PLoS ONE"},{"key":"978_CR17","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.4103\/1673-5374.172322","volume":"10","author":"MF Jiang","year":"2015","unstructured":"Jiang MF, Shi F, Niu GM, Xie SH, Yu SY (2015) A novel method for evaluating brain function and microstructural changes in Parkinson\u2019s disease. Neural Regen Res 10:2025\u20132032","journal-title":"Neural Regen Res"},{"key":"978_CR18","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1126\/science.1140481","volume":"317","author":"J Kim","year":"2007","unstructured":"Kim J, Inoue K, Ishii J, Vanti WB, Voronov SV, Murchison E, Hannon G, Abeliovich A (2007) A MicroRNA feedback circuit in midbrain dopamine neurons. Science 317:1220\u20131224","journal-title":"Science"},{"key":"978_CR19","doi-asserted-by":"crossref","unstructured":"Kim KY, Shin KY, Chang KA (2024) Potential Exosome Biomarkers for Parkinson\u2019s Disease Diagnosis: A Sys tematic Review and Meta-Analysis. Int J Mol Sci 25(10):5307","DOI":"10.3390\/ijms25105307"},{"key":"978_CR20","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/s41531-025-00976-3","volume":"11","author":"J Langley","year":"2025","unstructured":"Langley J, Hwang KS, Huddleston DE, Hu XP, Parkinson\u2019s Progression Marker I (2025) Nigral volume loss in prodromal, early, and moderate Parkinson\u2019s disease. NPJ Parkinsons Dis 11:181","journal-title":"NPJ Parkinsons Dis"},{"key":"978_CR21","doi-asserted-by":"crossref","unstructured":"Leggio L, Vivarelli S, L\u2019Episcopo F, Tirolo C, Caniglia S, Testa N, Marchetti B, Iraci N (2017) microRNAs in Parkinson\u2019s Disease: From Pathogenesis to Novel Diagnostic and Therapeutic Approaches. Int J Mol Sci 18(12):269","DOI":"10.3390\/ijms18122698"},{"key":"978_CR22","doi-asserted-by":"publisher","first-page":"20728","DOI":"10.18632\/aging.104005","volume":"12","author":"J Li","year":"2020","unstructured":"Li J, Li D, Zhou H, Wu G, He Z, Liao W, Li Y, Zhi Y (2020) MicroRNA-338-5p alleviates neuronal apoptosis via directly targeting BCL2L11 in APP\/PS1 mice. Aging 12:20728\u201320742","journal-title":"Aging"},{"key":"978_CR23","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1007\/s12264-017-0183-5","volume":"33","author":"S Lotankar","year":"2017","unstructured":"Lotankar S, Prabhavalkar KS, Bhatt LK (2017) Biomarkers for Parkinson\u2019s Disease: Recent Advancement. Neurosci Bull 33:585\u2013597","journal-title":"Neurosci Bull"},{"key":"978_CR24","doi-asserted-by":"crossref","unstructured":"Lu C, Cai X, Zhi S, Wen X, Shen J, Ercoli T, Simula ER, Masala C, Sechi LA, Solla P (2024) Exploring the Association between Cathepsin B and Parkinson\u2019s Disease. Brain Sci 14(5):48","DOI":"10.3390\/brainsci14050482"},{"key":"978_CR25","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1080\/21655979.2021.2005990","volume":"13","author":"Q Ma","year":"2022","unstructured":"Ma Q, Yang T (2022) E2F transcription factor 1\/small nucleolar RNA host gene 18\/microRNA-338-5p\/forkhead box D1: an important regulatory axis in glioma progression. Bioengineered 13:418\u2013430","journal-title":"Bioengineered"},{"key":"978_CR26","first-page":"1813","volume":"15","author":"ZL Ma","year":"2024","unstructured":"Ma ZL, Wang ZL, Zhang FY, Liu HX, Mao LH, Yuan L (2024) Biomarkers of Parkinson\u2019s Disease: From Basic Research to Clinical Practice. Aging Dis 15:1813\u20131830","journal-title":"Aging Dis"},{"key":"978_CR27","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1016\/j.ymthe.2017.08.017","volume":"25","author":"KJ McMillan","year":"2017","unstructured":"McMillan KJ, Murray TK, Bengoa-Vergniory N, Cordero-Llana O, Cooper J, Buckley A, Wade-Martins R, Uney JB, O\u2019Neill MJ, Wong LF et al (2017) Loss of MicroRNA-7 Regulation Leads to alpha-Synuclein Accumulation and Dopaminergic Neuronal Loss In Vivo. Mol Ther 25:2404\u20132414","journal-title":"Mol Ther"},{"key":"978_CR28","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.bbapap.2019.03.001","volume":"1867","author":"S Mehra","year":"2019","unstructured":"Mehra S, Sahay S, Maji SK (2019) alpha-Synuclein misfolding and aggregation: Implications in Parkinson\u2019s disease pathogenesis. Biochim Biophys Acta Proteins Proteom 1867:890\u2013908","journal-title":"Biochim Biophys Acta Proteins Proteom"},{"key":"978_CR29","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.jns.2017.09.033","volume":"382","author":"RM Naduthota","year":"2017","unstructured":"Naduthota RM, Honnedevasthana AA, Lenka A, Saini J, Geethanath S, Bharath RD, Christopher R, Yadav R, Gupta AK, Pal PK (2017) Association of freezing of gait with nigral iron accumulation in patients with Parkinson\u2019s disease. J Neurol Sci 382:61\u201365","journal-title":"J Neurol Sci"},{"key":"978_CR30","doi-asserted-by":"crossref","unstructured":"Nagatsu T, Nakashima A, Watanabe H, Ito S, Wakamatsu K (2022) Neuromelanin in Parkinson\u2019s Disease: Tyrosine Hydroxylase and Tyrosinase. Int J Mol Sci 23(8):4176","DOI":"10.3390\/ijms23084176"},{"issue":"Suppl 1","key":"978_CR31","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1111\/jnc.13750","volume":"139","author":"W Oertel","year":"2016","unstructured":"Oertel W, Schulz JB (2016) Current and experimental treatments of Parkinson disease: A guide for neuroscientists. J Neurochem 139(Suppl 1):325\u2013337","journal-title":"J Neurochem"},{"key":"978_CR32","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1177\/1877718X241308168","volume":"15","author":"OJ Olaoye","year":"2025","unstructured":"Olaoye OJ, Farrow SL, Nyaga DM, Cooper AA, O\u2019Sullivan JM (2025) From blood vessels to brain cells: Connecting the circulatory system and Parkinson\u2019s disease. J Parkinsons Dis 15:255\u2013268","journal-title":"J Parkinsons Dis"},{"key":"978_CR33","doi-asserted-by":"crossref","unstructured":"Paccosi E, Proietti-De-Santis L (2023) Parkinson\u2019s Disease: From Genetics and Epigenetics to Treatment, a miRNA-Based Strategy. Int J Mol Sci 24(11):9547","DOI":"10.3390\/ijms24119547"},{"key":"978_CR34","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1261\/rna.939908","volume":"14","author":"HJ Peltier","year":"2008","unstructured":"Peltier HJ, Latham GJ (2008) Normalization of microRNA expression levels in quantitative RT-PCR assays: identification of suitable reference RNA targets in normal and cancerous human solid tissues. RNA 14:844\u2013852","journal-title":"RNA"},{"key":"978_CR35","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.cortex.2022.03.009","volume":"151","author":"P Pieperhoff","year":"2022","unstructured":"Pieperhoff P, Sudmeyer M, Dinkelbach L, Hartmann CJ, Ferrea S, Moldovan AS, Minnerop M, Diaz-Pier S, Schnitzler A, Amunts K (2022) Regional changes of brain structure during progression of idiopathic Parkinson\u2019s disease - A longitudinal study using deformation based morphometry. Cortex 151:188\u2013210","journal-title":"Cortex"},{"key":"978_CR36","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, Obeso J, Marek K, Litvan I, Lang AE et al (2015) MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov Disord 30:1591\u20131601","journal-title":"Mov Disord"},{"key":"978_CR37","doi-asserted-by":"publisher","first-page":"4404","DOI":"10.1096\/fj.201801846R","volume":"33","author":"Q Qian","year":"2019","unstructured":"Qian Q, Zhang J, He FP, Bao WX, Zheng TT, Zhou DM, Pan HY, Zhang H, Zhang XQ, He X et al (2019) Down-regulated expression of microRNA-338-5p contributes to neuropathology in Alzheimer\u2019s disease. FASEB J 33:4404\u20134417","journal-title":"FASEB J"},{"key":"978_CR38","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/s41531-024-00791-2","volume":"10","author":"N Shaheen","year":"2024","unstructured":"Shaheen N, Shaheen A, Osama M, Nashwan AJ, Bharmauria V, Flouty O (2024) MicroRNAs regulation in Parkinson\u2019s disease, and their potential role as diagnostic and therapeutic targets. NPJ Parkinsons Dis 10:186","journal-title":"NPJ Parkinsons Dis"},{"key":"978_CR39","doi-asserted-by":"publisher","first-page":"3608","DOI":"10.1111\/bcp.14777","volume":"87","author":"Y Sheng","year":"2021","unstructured":"Sheng Y, Zhou X, Yang S, Ma P, Chen C (2021) Modelling item scores of Unified Parkinson\u2019s Disease Rating Scale Part III for greater trial efficiency. Br J Clin Pharmacol 87:3608\u20133618","journal-title":"Br J Clin Pharmacol"},{"key":"978_CR40","doi-asserted-by":"publisher","first-page":"e0295069","DOI":"10.1371\/journal.pone.0295069","volume":"19","author":"A Sokolowski","year":"2024","unstructured":"Sokolowski A, Bhagwat N, Chatelain Y, Dugre M, Hanganu A, Monchi O, McPherson B, Wang M, Poline JB, Sharp M et al (2024) Longitudinal brain structure changes in Parkinson\u2019s disease: A replication study. PLoS ONE 19:e0295069","journal-title":"PLoS ONE"},{"key":"978_CR41","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s11064-025-04405-y","volume":"50","author":"YW Sun","year":"2025","unstructured":"Sun YW, Lei XY, Lyu XY, Yin Y, Kan SJ, Wang ZM, Gao B (2025) Decoupling of Neurochemical and White Matter Microstructural Integrity in Posterior Cingulate Cortex Predicts Early Alzheimer\u2019s Disease Progression. Neurochem Res 50:159","journal-title":"Neurochem Res"},{"key":"978_CR42","doi-asserted-by":"publisher","first-page":"1604399","DOI":"10.3389\/fncom.2025.1604399","volume":"19","author":"X Teng","year":"2025","unstructured":"Teng X, Li X, Wei B (2025) ModFus-PD: synergizing cross-modal attention and contrastive learning for enhanced multimodal diagnosis of Parkinson\u2019s disease. Front Comput Neurosci 19:1604399","journal-title":"Front Comput Neurosci"},{"key":"978_CR43","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S1474-4422(21)00030-2","volume":"20","author":"E Tolosa","year":"2021","unstructured":"Tolosa E, Garrido A, Scholz SW, Poewe W (2021) Challenges in the diagnosis of Parkinson\u2019s disease. Lancet Neurol 20:385\u2013397","journal-title":"Lancet Neurol"},{"key":"978_CR44","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s00702-017-1686-y","volume":"124","author":"OB Tysnes","year":"2017","unstructured":"Tysnes OB, Storstein A (2017) Epidemiology of Parkinson\u2019s disease. J Neural Transm (Vienna) 124:901\u2013905","journal-title":"J Neural Transm (Vienna)"},{"key":"978_CR45","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1002\/mds.27447","volume":"33","author":"M Wanneveich","year":"2018","unstructured":"Wanneveich M, Moisan F, Jacqmin-Gadda H, Elbaz A, Joly P (2018) Projections of prevalence, lifetime risk, and life expectancy of Parkinson\u2019s disease (2010\u20132030) in France. Mov Disord 33:1449\u20131455","journal-title":"Mov Disord"},{"key":"978_CR46","doi-asserted-by":"publisher","first-page":"617308","DOI":"10.3389\/fncel.2021.617308","volume":"15","author":"M Warepam","year":"2021","unstructured":"Warepam M, Mishra AK, Sharma GS, Kumari K, Krishna S, Khan MSA, Rahman H, Singh LR (2021) Brain Metabolite, N-Acetylaspartate Is a Potent Protein Aggregation Inhibitor. Front Cell Neurosci 15:617308","journal-title":"Front Cell Neurosci"},{"key":"978_CR47","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.4103\/1673-5374.121625","volume":"8","author":"J Xia","year":"2013","unstructured":"Xia J, Miu J, Ding H, Wang X, Chen H, Wang J, Wu J, Zhao J, Huang H, Tian W (2013) Changes of brain gray matter structure in Parkinson\u2019s disease patients with dementia. Neural Regen Res 8:1276\u20131285","journal-title":"Neural Regen Res"},{"key":"978_CR48","doi-asserted-by":"publisher","first-page":"7961","DOI":"10.21037\/qims-23-267","volume":"13","author":"Y Yan","year":"2023","unstructured":"Yan Y, Wang Z, Wei W, Yang Z, Guo L, Wang Z, Wei X (2023) Correlation of brain iron deposition and freezing of gait in Parkinson\u2019s disease: a cross-sectional study. Quant Imaging Med Surg 13:7961\u20137972","journal-title":"Quant Imaging Med Surg"},{"key":"978_CR49","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1111\/ejn.16207","volume":"59","author":"MY Zamanian","year":"2024","unstructured":"Zamanian MY, Ivraghi MS, Gupta R, Prasad KDV, Alsaab HO, Hussien BM, Ahmed H, Ramadan MF, Golmohammadi M, Nikbakht N et al (2024) miR-221 and Parkinson\u2019s disease: A biomarker with therapeutic potential. Eur J Neurosci 59:283\u2013297","journal-title":"Eur J Neurosci"}],"container-title":["Cytotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10616-026-00978-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10616-026-00978-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10616-026-00978-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T08:02:04Z","timestamp":1783756924000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10616-026-00978-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,9]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["978"],"URL":"https:\/\/doi.org\/10.1007\/s10616-026-00978-w","relation":{},"ISSN":["0920-9069","1573-0778"],"issn-type":[{"value":"0920-9069","type":"print"},{"value":"1573-0778","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,9]]},"assertion":[{"value":"4 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"110"}}